Company

HilleVax

Biotechnology Research Boston, Ma, United States 32 employees

Employees: 32
Contacts: 3
Emails: 3
Phones: 3

www.hillevax.com LinkedIn Crunchbase

HilleVax Overview

Headquarters: Boston, Ma, United States
Website: www.hillevax.com
Industry: Biotechnology Research
Employees: 32
Founded: 2021
Funding: 100.0M
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

About HilleVax

HilleVax is a biopharmaceutical company focused on the development and commercialization of novel vaccines. Our initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate in development for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection.

HilleVax Contact Details

People in AeroLeads: 4
With contact data: 3
Email contacts: 3; 75.0% coverage
Phone contacts: 3; 75.0% coverage

HilleVax Org Chart

Sample employees and titles

Name	Title	Location	Contact
Michael Abram	Executive Scientific Leader	Raleigh, North Carolina, United States	Email Phone
Shane Maltbie	Chief Financial Officer at Hillevax		View
John Markels, Ph.d.	Leader. Healthcare Executive. Board	Kenilworth, New Jersey, United States	Email Phone
Paul S. Bavier	General Counsel and Chief	Cambridge, Massachusetts, United States	Email Phone